Increased HLA class II risk is associated with a more aggressive presentation of clinical type 1 diabetes

被引:6
|
作者
Kielevainen, Vilma [1 ]
Turtinen, Maaret [2 ,3 ]
Luopajarvi, Kristiina [2 ,3 ]
Harkonen, Taina [3 ]
Ilonen, Jorma [4 ]
Knip, Mikael [2 ,3 ,5 ]
机构
[1] Univ Eastern Finland, Fac Hlth Sci, Kuopio, Finland
[2] Helsinki Univ Hosp, New Childrens Hosp, Pediat Res Ctr, Helsinki, Finland
[3] Univ Helsinki, Fac Med, Res Program Clin & Mol Metab, Helsinki, Finland
[4] Univ Turku, Inst Biomed, Immunogenet Lab, Turku, Finland
[5] Tampere Univ Hosp, Tampere Ctr Child Hlth Res, Tampere, Finland
关键词
clinical characteristics; diagnosis; HLA class II; type; 1; diabetes; BETA-CELL AUTOIMMUNITY; GENETIC SUSCEPTIBILITY; FAMILY-HISTORY; CHILDREN; KETOACIDOSIS; DIAGNOSIS; ONSET; CHILDHOOD; GENOTYPES; ALLELES;
D O I
10.1111/apa.16621
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: To determine the association of HLA class II risk with the demographic and clinical characteristics of type 1 diabetes at diagnosis.Methods: We conducted a register- based retrospective cohort study of 4993 Finnish children (2169 girls) - diagnosed with type 1 diabetes under the age of 15 years in 2003- 2016. The participants were divided into six risk groups based on their HLA DR/DQ genotype. Demographic characteristics, family history of type 1 diabetes and metabolic markers at the time of diagnosis were compared between the groups.Results: In total, 4056/4993 children (81.2%) carried an HLA genotype associated with an increased risk of type 1 diabetes (risk groups 3- 5), whereas 937/4993 children (18.8%) carried a HLA genotype conferring no or decreased disease risk. Children with higher HLA risk were younger at diagnosis (p < 0.001) and had a shorter duration of classical symptoms before diagnosis (p = 0.016). Subjects in the high- risk group were more likely to have a family member affected by type 1 diabetes when compared to those in the neutral risk group (11.5% vs. 8.8%, p = 0.05).Conclusion: Children with stronger HLA disease susceptibility are younger at their disease manifestation and have a shorter period of symptoms before diagnosis, suggesting that the HLA class II genes are associated with a more aggressive disease presentation.
引用
收藏
页码:522 / 528
页数:7
相关论文
共 50 条
  • [1] Progression of type 1 diabetes associated autoimmunity and the high-risk HLA class II genotype
    Ilonen, J.
    Lempainen, J.
    Hammais, A.
    Laine, A. -P.
    Hermann, R.
    Veijola, R.
    Simell, O.
    Harkonen, T.
    Knip, M.
    DIABETOLOGIA, 2011, 54 : S150 - S151
  • [2] HLA class I and II alleles are associated with microvascular complications of type 1 diabetes
    Lipner, E. M.
    Tomer, Y.
    Noble, J. A.
    Monti, M. C.
    Lonsdale, J. T.
    Corso, B.
    Stewart, W. C. L.
    Greenberg, D. A.
    HUMAN IMMUNOLOGY, 2013, 74 (05) : 538 - 544
  • [3] HLA Class II and III Genetic Risk Factors of Type 1 Diabetes in Somali
    Coshway, Loyal
    Bowden, Sasigarn
    Linter, Katherine
    Zhou, Bi
    Hoffman, Robert P.
    Yu, Chack-Yung
    DIABETES, 2016, 65 : A611 - A611
  • [4] HLA Class I and Class II Alleles Affecting the Progress of Type 1 Diabetes Associated Autoimmunity
    Ilonen, Jorma
    Lipponen, Kati
    Gombos, Zsofia
    Kiviniemi, Minna
    Siljander, Heli
    Hermann, Robert
    Veijola, Riitta
    Simell, Olli
    Knip, Mikael
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2010, 71 (06) : 482 - 483
  • [5] Class II HLA Genotype in Fulminant Type 1 Diabetes
    Tsutsumi, Chiharu
    Imagawa, Akihisa
    Ikegami, Hiroshi
    Makino, Hideichi
    Kobayashi, Tetsuro
    Hanafusa, Toshiaki
    DIABETES, 2009, 58 : A299 - A299
  • [6] Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity
    Ilonen, J.
    Kiviniemi, M.
    Lempainen, J.
    Simell, O.
    Toppari, J.
    Veijola, R.
    Knip, M.
    PEDIATRIC DIABETES, 2016, 17 : 8 - 16
  • [7] HLA class II alleles and haplotypes in Lithuanian children with type 1 diabetes and healthy children (HLA and type 1 diabetes)
    Skrodeniene, Erika
    Marciulionyte, Dalia
    Padaiga, Zilvinas
    Jasinskiene, Edita
    Sadauskaite-Kuehne, Vaiva
    Sanjeevi, Carani B.
    Ludvigsson, Johnny
    MEDICINA-LITHUANIA, 2010, 46 (08): : 505 - 510
  • [8] Effect of HLA Class I and Class II Alleles on Progression From Autoantibody Positivity to Overt Type 1 Diabetes in Children With Risk-Associated Class II Genotypes
    Lipponen, Kati
    Gombos, Zsofia
    Kiviniemi, Minna
    Siljander, Heli
    Lempainen, Johanna
    Hermann, Robert
    Veijola, Riitta
    Simell, Olli
    Knip, Mikael
    Ilonen, Jorma
    DIABETES, 2010, 59 (12) : 3253 - 3256
  • [9] Type II diabetes: Time for more aggressive therapy?
    Spann, SJ
    AMERICAN FAMILY PHYSICIAN, 1997, 56 (02) : 364 - &
  • [10] Heterogeneity in the presentation of clinical type 1 diabetes defined by the level of risk conferred by human leukocyte antigen class II genotypes
    Taka, Antti-Mathias
    Harkonen, Taina
    Vahasalo, Paula
    Lempainen, Johanna
    Veijola, Riitta
    Ilonen, Jorma
    Knip, Mikael
    PEDIATRIC DIABETES, 2022, 23 (02) : 219 - 227